Literature DB >> 18712339

[Infrarenal abdominal aortic aneurysm: endovascular repair with stent grafts].

M Wagner1, G Voshage, T Busch, P Landwehr.   

Abstract

As an alternative to surgery, endovascular therapy with stent grafts has become the second main treatment option for infrarenal abdominal aortic aneurysms. Unlike surgery, endovascular treatment with stent grafts is also applicable in patients unfit for open repair. Despite current improvements in endovascular repair devices, significant anatomic barriers still exclude this technique for a large number of patients. Computed tomography, magnetic resonance imaging, and ultrasound are essential for diagnostics, preintervention planning, and postintervention follow-up of abdominal aneurysms treated with stent grafts. This review covers etiology, pathology, and diagnostic aspects. Materials and methods for endovascular treatment of abdominal aortic aneurysms are presented in detail, and clinical results and complications are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18712339     DOI: 10.1007/s00117-008-1718-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

1.  Influence of endograft oversizing on device migration, endoleak, aneurysm shrinkage, and aortic neck dilation: results from the Zenith Multicenter Trial.

Authors:  W Charles Sternbergh; Samuel R Money; Roy K Greenberg; Timothy A M Chuter
Journal:  J Vasc Surg       Date:  2004-01       Impact factor: 4.268

2.  Clinical significance of type II endoleak after endovascular repair of abdominal aortic aneurysm.

Authors:  Dmitri V Gelfand; Geoffrey H White; Samuel E Wilson
Journal:  Ann Vasc Surg       Date:  2006-01       Impact factor: 1.466

Review 3.  Literature review of surgical management of abdominal aortic aneurysm.

Authors:  A Hallin; D Bergqvist; L Holmberg
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-09       Impact factor: 7.069

4.  Barriers to endovascular aortic aneurysm repair: past experience and implications for future device development.

Authors:  Mireille A Moise; Edward Y Woo; Omaida C Velazquez; Ronald M Fairman; Michael A Golden; Marc E Mitchell; Jeffrey P Carpenter
Journal:  Vasc Endovascular Surg       Date:  2006 May-Jun       Impact factor: 1.089

5.  Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. European Collaborators on Stent/graft techniques for aortic aneurysm repair.

Authors:  P L Harris; S R Vallabhaneni; P Desgranges; J P Becquemin; C van Marrewijk; R J Laheij
Journal:  J Vasc Surg       Date:  2000-10       Impact factor: 4.268

6.  Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms.

Authors:  Jan D Blankensteijn; Sjors E C A de Jong; Monique Prinssen; Arie C van der Ham; Jaap Buth; Steven M M van Sterkenburg; Hence J M Verhagen; Erik Buskens; Diederick E Grobbee
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

7.  Influence of severe infrarenal aortic neck angulation on complications at the proximal neck following endovascular AAA repair: a EUROSTAR study.

Authors:  Roel Hobo; Jur Kievit; Lina J Leurs; Jacob Buth
Journal:  J Endovasc Ther       Date:  2007-02       Impact factor: 3.487

Review 8.  Endoleaks after endovascular repair of abdominal aortic aneurysms.

Authors:  Richard A Baum; S William Stavropoulos; Ronald M Fairman; Jeffrey P Carpenter
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

Review 9.  [Imaging of aortic disease].

Authors:  P Reimer; R Vosshenrich; P Landwehr; M Storck
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

Review 10.  Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery.

Authors:  David C Brewster; Jack L Cronenwett; John W Hallett; K Wayne Johnston; William C Krupski; Jon S Matsumura
Journal:  J Vasc Surg       Date:  2003-05       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.